Teva
The curse of being Israel's most valuable company
Tower's share price has jumped nearly 900% in the past five years, but less than 24 hours after reaching the top, the world's chip stocks plummeted, and Tower's share price tumbled 10.79%
Mega deal: Teva acquires Emalex for approximately $900 million
IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience
Teva honored for gender equality as women reach 43% of senior management in Israel
Teva's profit beats forecasts, shares jump
Shares in the world’s largest generic drugmaker jumped nearly 20% in late Tel Aviv trade as the company also reaffirmed its 2020 outlook, despite disruption to the global economy from the coronavirus
Teva donates potential coronavirus treatment to hospitals across the US
Hydroxychloroquine sulfate tablets are used against malaria, lupus erythematosus and rheumatoid arthritis but could be effective against COVID-19.
After turbulent years, Teva CEO Schultz forecasts stability
Teva completed its two-year major restructuring plan in 2019, reducing its cost base by over $3 billion and net debt by more than $9b.
Teva's first ever National Forum for Bio-Innovators gathers in Tel Aviv
Researcher Hila Flayev has for years been conducting research on computational models of the coronavirus structure and interactions it can create.
Teva Naot launches store in Vancouver, Canada
In 2019, Teva Naot sold about 100,000 pairs of shoes in its stores and to retailers, and through the website in the Canadian market.
Teva’s proposed settlement could cost drugmaker pennies on the dollar
Israel-based Teva is looking to reach a nationwide settlement over its role in selling opioid painkillers, together with drugmaker Johnson & Johnson and the three largest U.S. drug distributors.
Teva shares surge amid hopes of $23 billion opioid claims settlement
Teva stocks also closed up 8.67% on the New York Stock Exchange on Monday amid growing optimism.
Opioid settlement talks fail with Teva, landmark trial expected Monday
After nearly 11 hours of negotiations, Pennsylvania Attorney General Josh Shapiro told reporters it was “profoundly disappointing” that local governments would not go along with a settlement.
Teva proposes $15 billion deal to settle opioid claims
The proposed settlement comes only days ahead of a landmark federal trial in Cleveland, Ohio, against the company and five drug distributors.
Teva joins medical cannabis market with Israel distribution deal
Under the agreement announced Friday, S.L.E. will distribute Canndoc's GMP-approved products to clients in Israel, including hospitals, health maintenance organizations (HMOs) and all pharmacies.
